Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03950492 · ClinicalTrials.gov registry record · NA
Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder
A NA study of Opioid-Related Disorders, sponsored by West Virginia University.
- Active
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT03950492: Active NA study of Opioid-Related Disorders, sponsored by West Virginia University.
NCT03950492 is a NA study of Opioid-Related Disorders that is active but no longer recruiting, run by West Virginia University. The registered enrollment target is 4 participants, below the 347-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03950492, a NA study of Opioid-Related Disorders, is active but no longer recruiting, sponsored by West Virginia University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical study is to investigate the safety, tolerability, and feasibility of Deep Brain Stimulation (DBS) of the nucleus accumbens (NAc) and ventral internal capsule (VC) for participants with treatment refractory opioid use disorder (OUD) who have cognitive, behavioral, and functional disability. This study will also provide critical information for planning subsequent clinical trials.
Primary Outcome
Study participants will be closely monitored for adverse events following DBS surgery with regular check-ups by study personnel.
Conditions Studied
Interventions
- DEVICE Deep Brain Simulator
Study Locations (1)
West Virginia
- West Virginia University Rockefeller Neuroscience Institute - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-09-30 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT03950492 still lists
NCT03950492 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 347-participant average among 47 other Opioid-Related Disorders trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Opioid-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Simulator is the first listed.
NCT03950492 reports a single indexed study location in West Virginia.
Frequently Asked Questions
What is clinical trial NCT03950492 about?
NCT03950492 is a clinical study titled "Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder". The purpose of this clinical study is to investigate the safety, tolerability, and feasibility of Deep Brain Stimulation (DBS) of the nucleus accumbens (NAc) and ventral internal capsule (VC) for participants with treatment refractory opioid use disorder (OUD) who have cognitive, behavioral, and fun...
What is the current status of trial NCT03950492?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 4 participants. The study started on 2019-09-30. Estimated completion is 2026-12-31.
What conditions does trial NCT03950492 study?
This clinical trial studies the following conditions: Opioid-Related Disorders.
What interventions are being tested in trial NCT03950492?
The interventions under investigation include: Deep Brain Simulator (DEVICE).
Who is sponsoring clinical trial NCT03950492?
This trial is sponsored by West Virginia University, which has 122 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03950492 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03950492's enrollment target sits among peer trials
4 48th of 47 the lowest of 47 other Opioid-Related Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Developing and Evaluating a Machine-Learning Opioid Overdose Prediction & Risk-Stratification Tool in Primary Care
RECRUITING · NA
-
Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment
RECRUITING · NA
-
OUD Smartphone Services
ACTIVE NOT RECRUITING · NA
-
Developing a Tailored Stigma Reduction Intervention to Increase Buprenorphine Prescribing
ACTIVE NOT RECRUITING · NA
-
Healthy Opioid Prescription Engagement
ACTIVE NOT RECRUITING · NA
-
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI